Cellectis (CLLS) Change in Inventory (2016 - 2021)
Cellectis (CLLS) recorded quarterly Change in Inventory of $289000.0 in Q4 2021, down 63.51% quarter-over-quarter from $792000.0 in Q3 2021, and down 91.63% on a YoY basis from $3.5 million in Q4 2020.
Cellectis (CLLS) Change in Inventory (2016 - 2021) Analysis & Trends
Cellectis' Change in Inventory history runs 6 years deep, the most recent figure standing at $289000.0 for Q4 2021.
- In Q4 2021, Change in Inventory fell 91.63% year-over-year to $289000.0; the TTM figure through Dec 2021 stood at $215000.0 (up 115.0% YoY), while the FY2021 annual figure was $215000.0, up 115.0% from the prior year.
- Change in Inventory was $289000.0 for Q4 2021 at Cellectis, down from $792000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $3.5 million in Q4 2020 to a low of -$3.7 million in Q1 2021.
- Historically, Change in Inventory has averaged -$122889.8 across 5 years, with a median of -$898.2 in 2017.
- Biggest YoY gain for Change in Inventory was 953.57% in 2019; the steepest drop was 34328.57% in 2019.
- A 5-year view of Change in Inventory shows it stood at -$116000.0 in 2017, then soared by 51.72% to -$56000.0 in 2018, then jumped by 953.57% to $478000.0 in 2019, then surged by 622.38% to $3.5 million in 2020, then slumped by 91.63% to $289000.0 in 2021.
- The last three Change in Inventory figures came in at $289000.0 (Q4 2021), $792000.0 (Q3 2021), and $2.9 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 289,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Jun 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Sep 30, 2020 | -540,000.00 |
| Sep 30, 2020 | -540,000.00 |
| Jun 30, 2020 | -2.11 Mn |
| Jun 30, 2020 | -2.11 Mn |
| Mar 31, 2020 | -702,000.00 |
| Mar 31, 2020 | -702,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Sep 30, 2019 | -2.40 Mn |
| Sep 30, 2019 | -2.40 Mn |